Affiliation: New South Wales
- Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000-2007Bernadette Aliprandi-Costa
Department of Cardiology, Concord Repatriation General Hospital, Sydney, NSW, Australia
Med J Aust 195:116-21. 2011..To describe temporal trends in the use of evidence-based medical therapies and management of patients with acute coronary syndromes (ACS) in Australia and New Zealand...
- Trends and predictors of rehospitalisation following an acute coronary syndrome: report from the Australian and New Zealand population of the Global Registry of Acute Coronary Events (GRACE)Prashanthi V Sangu
Department of Cardiology, Concord Repatriation General Hospital, Hospital Road, Concord, NSW 2139, Australia
Heart 98:1728-31. 2012..Readmission following an acute coronary syndrome (ACS) is frequent in our community. Patient specific factors identifying those at risk of readmission are poorly described...
- Optimizing adjunctive antithrombotic therapy in the treatment of acute myocardial infarction: a role for low-molecular-weight heparinDavid Brieger
Department of Cardiology, University of Sydney, Sydney, New South Wales, Australia
Clin Cardiol 27:3-8. 2004..Several randomized clinical trials have shown that adjunctive LMWH is at least as effective as UFH in the acute phase of MI, is associated with fewer in-hospital recurrent ischemic events, and has an acceptable safety profile...
- Acute coronary syndromes: consensus recommendations for translating knowledge into actionDavid Brieger
Concord Repatriation General Hospital, Sydney, NSW, Australia
Med J Aust 191:334-8. 2009..National standards for data collection and clinical outcomes should be established, and performance should be monitored...
- Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsD Brieger
Concord Repatriation General Hospital, Coronary Care Unit, Concord, NSW Australia
Heart 95:888-94. 2009..To identify patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) with a low likelihood of any adverse in-hospital event. Design, setting and..
- Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)David Brieger
Concord Hospital, Sydney, Australia
Am Heart J 153:960-9. 2007....
- Medications for the treatment of acute coronary syndromesDavid B Brieger
Department of Cardiology, Concord Repatriation General Hospital, Concord, NSW, 2137, Australia
Expert Opin Pharmacother 6:2843-54. 2005..Statins can impact on short-term outcomes when given during the acute admission; and this benefit is augmented if high doses are used...
- Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary EventsDavid Brieger
University of Sydney, Sydney, Australia
Chest 126:461-9. 2004..In this analysis, a large contemporary database has been accessed to define the frequency, clinical characteristics, and outcomes of patients presenting without chest pain across different diagnostic categories of ACS...
- An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney diseaseC Medi
Concord Hospital, Cardiology, Sydney, New South Wales, Australia
Intern Med J 41:743-50. 2011..Chronic kidney disease (CKD) is associated with poor outcomes after acute coronary syndromes, yet selection for invasive investigation and management is low...
- The design and rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE)B Aliprandi-Costa
Concord Repatriation General Hospital and The University of Sydney, Sydney, NSW, Australia
Heart Lung Circ 22:533-41. 2013....
- Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery diseaseB Zeng
Department of Cardiology, Concord Hospital, Vascular Biology Laboratory, ANZAC Research Institute, University of Sydney, Australia
Intern Med J 35:331-5. 2005..Matrix metalloproteinases (MMP-9 and MMP-2) have been implicated in development of atherosclerosis and plaque rupture in acute coronary syndromes (ACS)...
- Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registryDerek P Chew
Flinders University, Adelaide, SA
Med J Aust 188:691-7. 2008..To describe the impact of invasive management on 12-month survival among patients with suspected acute coronary syndrome (ACS) in Australia...